Syngenta/Caprotec agree research deal
Syngenta has agreed a joint research deal with German mass spectrometry company Caprotec Bioanalytics (Berlin). The agreement will provide Syngenta with access to Caprotec's proprietary capture compound mass spectrometry (CCMS) technology. The companies will work to profile the interactions of one of Syngenta's new active ingredients with the proteome in its relevant plant biological system. Caprotec's platform allows "an unbiased evaluation of the interactions of small molecules with protein mixtures in a targeted and directed manner, thereby facilitating the identification and elucidation of tractable targets as well as accelerating the development of promising leads", it says. Syngenta will cover the associated research costs and Caprotec will receive success-based milestone payments. In July, Caprotec extended a similar deal involving CCMS with Bayer CropScience (Agrow No 669, p 3).